Jean Seely

Jun 5, 2024 | winnipegfreepress.com | Anna Wilkinson |GP Oncologist |l’Université d’Ottawa |Jean Seely |Moira Katherine Rushton

This article was originally published on The Conversation, an independent and nonprofit source of news, analysis and commentary from academic experts. Disclosure information is available on the original site. ___Authors: Anna N.

Jun 3, 2024 | ledevoir.com | Jean Seely

Les récentes lignes directrices provisoires publiées par le Groupe d’étude canadien sur les soins de santé préventifs (GECSSP) concernant le dépistage du cancer du sein ont suscité de vives inquiétudes. En tant qu’experte faisant partie du comité d’examen des preuves, je trouve ces recommandations profondément décevantes. Elles ignorent des preuves solides et récentes en faveur du dépistage dès l’âge de 40 ans, adoptées aux États-Unis et ailleurs.

Aug 26, 2023 | mdpi.com | Anna Wilkinson |Jean Seely |Moira Katherine Rushton |Phillip Williams

1. IntroductionApproximately one in every eight women will be diagnosed with breast cancer (BC) over their lifetime, with an estimated 28,600 new cases of BC in Canada in 2022 [1,2]. BC treatment is rapidly evolving, with ongoing advances in genomic testing, radiation therapy, surgery and systemic therapy. BC molecular subtype, based on hormone receptor (HR) and HER2/neu (HER2) status, is increasingly driving specialised therapy choices and informing improved subtype-specific survival [3].

Mar 8, 2023 | mdpi.com | Jean Seely |J. J. M

Open AccessEditorialbyJean M. Seely Department of Radiology, The Ottawa Hospital, University of Ottawa, Ottawa, ON K1N 6N5, CanadaCurr. Oncol. 2023, 30(3), 3201-3205; https://doi.org/10.3390/curroncol30030242 (registering DOI)Received: 26 February 2023/Accepted: 3 March 2023/Published: 8 March 2023(This article belongs to the Special Issue Breast Cancer Imaging and Therapy) 1. IntroductionBreast cancer affects too many of us.